Literature DB >> 25416023

What is the role of the multidisciplinary team in the management of urinary incontinence?

Aswini Balachandran1, Jonathan Duckett.   

Abstract

Multidisciplinary teams (MDT) are a well-established part of service provision and clinical care in the UK. In 2013, the National Institute for Health and Care Excellence (NICE) Urinary Incontinence guideline recommended that MDT review should be mandatory before invasive therapy is offered to all patients with stress urinary incontinence (SUI) and overactive bladder (OAB). Currently, there is no evidence in the literature regarding the use of MDTs in urogynaecology. The aim of this paper is to assess the potential benefits and disadvantages of the creation of routine MDT meetings for the management of urinary incontinence.

Entities:  

Mesh：

Year:  2014        PMID： 25416023     DOI： 10.1007/s00192-014-2579-3

Source DB:  PubMed          Journal:  Int Urogynecol J        ISSN： 0937-3462            Impact factor:   2.894


  21 in total

1.  A multidisciplinary team approach to reducing medication variance.

Authors:  Terri A Sim; Julie Joyner
Journal:  Jt Comm J Qual Improv       Date:  2002-07

Review 2.  Examining the potential relationship between multidisciplinary cancer care and patient survival: an international literature review.

Authors:  Nicole J Look Hong; Frances C Wright; Anna R Gagliardi; Lawrence F Paszat
Journal:  J Surg Oncol       Date:  2010-08-01       Impact factor: 3.454

3.  Is the multidisciplinary team essential for the future management of patients with inflammatory bowel disease?

Authors:  A Windsor; A Forbes
Journal:  Colorectal Dis       Date:  2007-07       Impact factor: 3.788

4.  Surgeons' views on multi-disciplinary breast meetings.

Authors:  E J Macaskill; S Thrush; E M Walker; J M Dixon
Journal:  Eur J Cancer       Date:  2006-03-03       Impact factor: 9.162

5.  Group discussions with the health care team--a method of improving care of hypertension in general practice.

Authors:  D Adorian; D S Silverberg; D Tomer; Z Wamosher
Journal:  J Hum Hypertens       Date:  1990-06       Impact factor: 3.012

6.  Improvements in survival of gynaecological cancer in the Anglia region of England: are these an effect of centralisation of care and use of multidisciplinary management?

Authors:  R Crawford; D Greenberg
Journal:  BJOG       Date:  2011-04-12       Impact factor: 6.531

7.  General surgeons' views on Oncologic Multidisciplinary Group meetings as part of colorectal cancer care.

Authors:  Francesco Feroci; Elisa Lenzi; Maddalena Baraghini; Stefano Cantafio; Marco Scatizzi
Journal:  Updates Surg       Date:  2012-09-18

8.  A multidisciplinary approach: group dynamics.

Authors:  Tamar H Taddei
Journal:  J Clin Gastroenterol       Date:  2013-07       Impact factor: 3.062

9.  Multidisciplinary management of lung cancer: how to test its efficacy?

Authors:  Francesco Leo; Nicolas Venissac; Michel Poudenx; Josiane Otto; Jérôme Mouroux
Journal:  J Thorac Oncol       Date:  2007-01       Impact factor: 15.609

10.  An evaluation of the impact of a multidisciplinary team, in a single centre, on treatment and survival in patients with inoperable non-small-cell lung cancer.

Authors:  L M Forrest; D C McMillan; C S McArdle; D J Dunlop
Journal:  Br J Cancer       Date:  2005-10-31       Impact factor: 7.640
View more
  3 in total

1.  Joint position statement on the management of mesh-related complications for the FPMRS specialist.

Authors: 
Journal:  Int Urogynecol J       Date:  2020-04       Impact factor: 2.894

2.  It's About Time: The Temporal Burden of Lower Urinary Tract Symptoms Among Women.

Authors:  Beverly Rosa Williams; Keith Vargo; Diane K Newman; D Yvette Lacoursiere; Elizabeth R Mueller; John Connett; Lisa Kane Low; Aimee S James; Ariana L Smith; Kathryn H Schmitz; Kathryn L Burgio
Journal:  Urol Nurs       Date:  2020 Nov-Dec

3.  What is the role of the multidisciplinary team meeting in primary prolapse surgery and are alternative formats acceptable?

Authors:  Victoria Kershaw; Andrew Farkas; Stephen Radley; Swati Jha
Journal:  Int Urogynecol J       Date:  2022-09-09       Impact factor: 1.932
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.